Larimar Therapeutics
in the mad study | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
13 of 15
Related slides by other companies
Fusion Pharmaceuticals
Investor Presentation
November 2023
plasma and platelet counts | Fusion Pharmaceuticals
Fusion Pharmaceuticals
Investor Presentation
August 2023
plasma and platelet counts | Fusion Pharmaceuticals
ATAI
Investor Presentation
March 2023
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk preliminary data subject to change phase the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
MindMed
Investor Presentation
November 2024
for gad phase study designs voyage panorama | MindMed
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Investor Presentation
November 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights